These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 28836465

  • 1. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.
    Guo LN, Xiao M, Cao B, Qu F, Zhan YL, Hu YJ, Wang XR, Liang GW, Gu HT, Qi J, Yuan H, Min R, Wang FY, Liu LJ, Wang HB, Jiang W, Duan XG, Xu WJ, Yu YH, Su JR, Zhang JZ, Nong JQ, Liu SM, Li J, Liu JT, Yue ZG, Yang D, Guo J, Zhao R, Zhang YN, Yang XM, Liu XQ, Hsueh PR, Xu YC.
    Future Microbiol; 2017 Sep; 12():1075-1086. PubMed ID: 28836465
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
    Wang H, Xu YC, Hsueh PR.
    Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
    [Abstract] [Full Text] [Related]

  • 3. Changing epidemiology of candidaemia in Australia.
    Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, Bak N, Heath CH, Kennedy K, Morrissey CO, Sorrell TC, van Hal S, Keighley C, Goeman E, Underwood N, Hajkowicz K, Hofmeyr A, Leung M, Macesic N, Botes J, Blyth C, Cooley L, George CR, Kalukottege P, Kesson A, McMullan B, Baird R, Robson J, Korman TM, Pendle S, Weeks K, Liu E, Cheong E, Chen S, Australian and New Zealand Mycoses Interest Group.
    J Antimicrob Chemother; 2017 Apr 01; 72(4):1103-1108. PubMed ID: 28364558
    [Abstract] [Full Text] [Related]

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov 01; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 5. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M, Deshpande LM, Messer SA, Rhomberg PR, Pfaller MA.
    Int J Antimicrob Agents; 2020 Jan 01; 55(1):105799. PubMed ID: 31520783
    [Abstract] [Full Text] [Related]

  • 6. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M, Fan X, Chen SC, Wang H, Sun ZY, Liao K, Chen SL, Yan Y, Kang M, Hu ZD, Chu YZ, Hu TS, Ni YX, Zou GL, Kong F, Xu YC.
    J Antimicrob Chemother; 2015 Mar 01; 70(3):802-10. PubMed ID: 25473027
    [Abstract] [Full Text] [Related]

  • 7. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
    Sadeghi G, Ebrahimi-Rad M, Mousavi SF, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M.
    J Mycol Med; 2018 Mar 01; 28(1):51-58. PubMed ID: 29366545
    [Abstract] [Full Text] [Related]

  • 8. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M, Deshpande LM, Davis AP, Rhomberg PR, Pfaller MA.
    Antimicrob Agents Chemother; 2017 Oct 01; 61(10):. PubMed ID: 28784671
    [Abstract] [Full Text] [Related]

  • 9. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures.
    Megri Y, Arastehfar A, Boekhout T, Daneshnia F, Hörtnagl C, Sartori B, Hafez A, Pan W, Lass-Flörl C, Hamrioui B.
    Antimicrob Resist Infect Control; 2020 Apr 07; 9(1):50. PubMed ID: 32264966
    [Abstract] [Full Text] [Related]

  • 10. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Lindberg E, Hammarström H, Ataollahy N, Kondori N.
    Sci Rep; 2019 Mar 07; 9(1):3838. PubMed ID: 30846717
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
    Tasneem U, Siddiqui MT, Faryal R, Shah AA.
    J Pak Med Assoc; 2017 Jul 07; 67(7):986-991. PubMed ID: 28770873
    [Abstract] [Full Text] [Related]

  • 12. APX001A In Vitro Activity against Contemporary Blood Isolates and Candida auris Determined by the EUCAST Reference Method.
    Arendrup MC, Chowdhary A, Astvad KMT, Jørgensen KM.
    Antimicrob Agents Chemother; 2018 Oct 07; 62(10):. PubMed ID: 30104264
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
    Arastehfar A, Yazdanpanah S, Bakhtiari M, Fang W, Pan W, Mahmoudi S, Pakshir K, Daneshnia F, Boekhout T, Ilkit M, Perlin DS, Zomorodian K, Zand F.
    Med Mycol; 2021 May 04; 59(5):422-430. PubMed ID: 32692816
    [Abstract] [Full Text] [Related]

  • 14. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study.
    Xiao M, Sun ZY, Kang M, Guo DW, Liao K, Chen SC, Kong F, Fan X, Cheng JW, Hou X, Zhou ML, Li Y, Yu SY, Huang JJ, Wang H, Xu YC, China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study Group.
    J Clin Microbiol; 2018 Jul 04; 56(7):. PubMed ID: 29743305
    [Abstract] [Full Text] [Related]

  • 15. Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.
    De Francesco MA, Piccinelli G, Gelmi M, Gargiulo F, Ravizzola G, Pinsi G, Peroni L, Bonfanti C, Caruso A.
    Mycopathologia; 2017 Oct 04; 182(9-10):897-905. PubMed ID: 28597394
    [Abstract] [Full Text] [Related]

  • 16. Antifungal susceptibility of Candida isolates at one institution.
    Katsuragi S, Sata M, Kobayashi Y, Miyoshi T, Yamashita Y, Neki R, Horiuchi C, Yamanaka K, Kamiya C, Iwanaga N, Tanaka H, Ikeda T, Yoshimatsu J.
    Med Mycol J; 2014 Oct 04; 55(1):E1-7. PubMed ID: 24682093
    [Abstract] [Full Text] [Related]

  • 17. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
    Ohta C, Yamane N, Nakasone I, Onaga S, Nakamura K.
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005 Oct 04; 16(2):127-33. PubMed ID: 16536058
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.
    Taj-Aldeen SJ, Kolecka A, Boesten R, Alolaqi A, Almaslamani M, Chandra P, Meis JF, Boekhout T.
    Infection; 2014 Apr 04; 42(2):393-404. PubMed ID: 24352810
    [Abstract] [Full Text] [Related]

  • 19. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
    Rodriguez L, Bustamante B, Huaroto L, Agurto C, Illescas R, Ramirez R, Diaz A, Hidalgo J.
    PLoS One; 2017 Apr 04; 12(4):e0175172. PubMed ID: 28419092
    [Abstract] [Full Text] [Related]

  • 20. Risk factors and outcomes of candidemia caused by Candida parapsilosis complex in a medical center in northern Taiwan.
    Wu YM, Huang PY, Lu JJ, Shie SS, Ye JJ, Wu TS, Huang CT.
    Diagn Microbiol Infect Dis; 2018 Jan 04; 90(1):44-49. PubMed ID: 29132935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.